However, we still observe 30 % of relapse, mainly with metastatic stage, with less than 20 % long-term survival for these patients [3]. The role of chemotherapy in recurrent osteosarcomas is not fully established [4]. There is no standard regimen recommended for second-line treatment [1, ...